100% Quality Guarantee
PhD-Level Technical Support
Epigenetics and Nuclear Signaling Antibodies 3 Anti-ATRX Antibody CAB17378
Key Features

ATRX Polyclonal Antibody (CAB17378)

SKU CAB17378
Product Type Antibody
Antibody Type Polyclonal Antibody
Reactivity Human, Mouse
Host Species Rabbit
Synonyms JMS, XH2, XNP, MRX52, RAD54, RAD54L, ZNF-HX, ATRX
Research Use Epigenetics and Nuclear Signaling
€96 - €370

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

ATRX Polyclonal Antibody (CAB17378)

The ATRX Polyclonal Antibody (CAB17378) is a high-quality antibody developed for reliable detection and analysis of target proteins. This antibody, raised in rabbits, has high reactivity with human, mouse, and rat samples, and has been validated for use in various applications such as Western blot and immunohistochemistry.ATRX is known for its role in maintaining genome stability and telomere length, making it an important factor in cell proliferation and differentiation. Dysregulation of ATRX has been associated with various cancers, developmental disorders, and neurodegenerative diseases, highlighting its potential as a therapeutic target.

This antibody is validated for use in WB, ELISA applications and has demonstrated reactivity against Human, Mouse samples.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose